Proteus mirabilis

Proteus mirabilis is a gram-negative bacterium that is commonly associated with urinary tract infections (UTIs), particularly in individuals with long-term catheterization. 

It is known for its ability to rapidly swarm across solid surfaces, a characteristic that contributes to its pathogenicity. This organism is primarily found in the human intestinal tract but can cause infections when it translocates to other body sites.

Biochemical Characteristics

The identification of Proteus mirabilis involves several biochemical tests. It is indole-negative, unlike its close relative, Proteus vulgaris, which is indole-positive. It produces urease, which hydrolyzes urea into ammonia and carbon dioxide, creating an alkaline environment. This property contributes to the formation of struvite stones in the urinary tract.

ICD-10 Coding for Proteus mirabilis Infections

In the International Classification of Diseases, Tenth Revision (ICD-10), Proteus mirabilis infections are coded based on the type and site of infection. For instance, a urinary tract infection caused by Proteus species is coded as N39.0.

---

Causes of Proteus mirabilis

Proteus mirabilis infections are often opportunistic, occurring in individuals with compromised immunity or those with indwelling medical devices such as catheters.

Swarming Motility and Biofilm Formation

The swarming motility of Proteus mirabilis enables it to colonize the urinary tract effectively. This movement is facilitated by flagella, which also play a role in biofilm formation. Biofilms are structured communities of bacteria that adhere to surfaces and are resistant to antibiotics, making infections difficult to treat.

Urease Activity and Stone Formation

The urease enzyme produced by Proteus mirabilis is a significant virulence factor. By breaking down urea into ammonia, it increases urine pH, leading to the precipitation of magnesium ammonium phosphate (struvite) stones. These stones can obstruct the urinary tract, exacerbating infections and causing kidney damage.

---

Symptoms of Proteus mirabilis Infections

The symptoms of Proteus mirabilis infections vary based on the site of infection. Common manifestations include:

Early diagnosis and treatment are crucial to prevent complications such as renal damage or systemic infection.

---

Diagnosis of Proteus mirabilis Infections

The diagnosis of Proteus mirabilis involves a combination of clinical evaluation and laboratory testing.

Culture and Sensitivity Testing

Urine, blood, or wound cultures are used to isolate the organism. Sensitivity testing helps determine the most effective antibiotics for treatment.

Biochemical Tests

Biochemical tests play a pivotal role in identifying Proteus mirabilis. These include:

Molecular Methods

Polymerase chain reaction (PCR) and other molecular techniques can be used to detect specific genetic markers of Proteus mirabilis, offering rapid and precise diagnosis.

---

Treatment of Proteus mirabilis Infections

Effective treatment requires addressing both the bacterial infection and any associated complications, such as stone formation.

Antibiotic Therapy

Proteus mirabilis is generally susceptible to a range of antibiotics, including ampicillin and cephalosporins. However, resistance is an emerging concern, necessitating culture and sensitivity testing to guide therapy.

Management of Complications

For patients with urinary tract stones, surgical intervention may be necessary to remove obstructions. Preventing stone recurrence involves managing risk factors such as urine pH and hydration.

---

Prevention of Proteus mirabilis Infections

Preventive measures focus on minimizing risk factors and enhancing infection control practices.

Catheter Management

For patients requiring long-term catheterization, regular catheter changes and proper hygiene are essential to prevent colonization by Proteus mirabilis.

Prophylactic Antibiotics

In certain high-risk populations, prophylactic antibiotics may be considered to prevent recurrent infections. However, this approach should be carefully weighed against the risk of antibiotic resistance.